These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 8749950

  • 21. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P.
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [Abstract] [Full Text] [Related]

  • 22. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK, Seipelt G, Langenhan S, Reutzel R, Schott D, Schoeffski O, Illiger HJ, Hartmann F, Balleisen L, Franke A, Fiedler F, Huber C, Rasche H, Bergmann L, Ganser A, Pott C, Pasold R, Rudolph C, Ottmann OG, Gökbuget N, Hoelzer D.
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [Abstract] [Full Text] [Related]

  • 23. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.
    Can J Urol; 2002 Oct 15; 9(5):1625-33. PubMed ID: 12431323
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 29. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
    Tung N, Berkowitz R, Matulonis U, Quartulli M, Seiden M, Kim Y, Niloff J, Cannistra SA.
    Gynecol Oncol; 2000 May 15; 77(2):271-7. PubMed ID: 10785477
    [Abstract] [Full Text] [Related]

  • 30. The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
    De Placido S, Lauria R, Carlomagno C, Perrone F, De Laurentiis M, Gallo C, Martignetti A, Bellelli T, Limite G, Petrella G, Bianco AR.
    Int J Oncol; 1999 Aug 15; 15(2):339-46. PubMed ID: 10402245
    [Abstract] [Full Text] [Related]

  • 31. Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
    Holdsworth MT, Roon R, Ferguson J, Martinez L, Stidley CA, Neidhart JA.
    Biotechnol Ther; 1993 Aug 15; 4(3-4):183-95. PubMed ID: 8292969
    [Abstract] [Full Text] [Related]

  • 32. [Effect of recombinant human granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium receiving methotrexate, etoposide and cisplatinum combination chemotherapy].
    Miura T, Murai T, Shimura H, Kondo I.
    Hinyokika Kiyo; 1993 Mar 15; 39(3):209-12. PubMed ID: 7685138
    [Abstract] [Full Text] [Related]

  • 33. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T, Sakaguchi H, Kajikawa H, Nishioka T.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [Abstract] [Full Text] [Related]

  • 34. [M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
    Noguchi S, Kubota Y, Shuin T, Masuda M, Misaki H, Yao M, Kondoh K, Sakuramoto T, Hosaka M.
    Hinyokika Kiyo; 1994 Aug 15; 40(8):677-82. PubMed ID: 7942364
    [Abstract] [Full Text] [Related]

  • 35. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK, Zhou JC, Feng FY.
    Zhonghua Zhong Liu Za Zhi; 1994 May 15; 16(3):207-10. PubMed ID: 7525173
    [Abstract] [Full Text] [Related]

  • 36. Dose-intensive chemotherapy with cisplatin, vincristine, doxorubicin and etoposide against lung cancer: a pilot study.
    Yanagawa H, Bando H, Takishita Y.
    Anticancer Res; 1995 May 15; 15(2):613-6. PubMed ID: 7539241
    [Abstract] [Full Text] [Related]

  • 37. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
    Al-Sarraf M, Frank J, Smith JA, O'Bryan RM, Costanzi JJ, Stephens RL, Caraveo J, Crawford ED.
    Cancer Treat Rep; 1985 Feb 15; 69(2):189-94. PubMed ID: 2578880
    [Abstract] [Full Text] [Related]

  • 38. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H, Ishikawa J, Kitayama H, Yamagami T, Hiraoka A, Nakamura H, Shibata H, Masaoka T, Takaku F.
    Exp Hematol; 1989 Sep 15; 17(8):853-8. PubMed ID: 2475358
    [Abstract] [Full Text] [Related]

  • 39. [Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
    Oyama A, Ota K, Asano S, Takaku F, Miyazaki T, Uzuka Y, Omine M, Furusawa S, Hirashima K, Sanpi K.
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug 20; 25(8):1619-34. PubMed ID: 1700040
    [Abstract] [Full Text] [Related]

  • 40. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Shi YK, Sun Y, Su M.
    Zhonghua Zhong Liu Za Zhi; 1994 Sep 20; 16(5):356-9. PubMed ID: 7895587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.